This HTML5 document contains 89 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n12https://global.dbpedia.org/id/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n15http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
n14http://commons.wikimedia.org/wiki/Special:FilePath/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbchttp://dbpedia.org/resource/Category:
dbphttp://dbpedia.org/property/
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:N-Ethylpentylone
rdf:type
owl:Thing dbo:Drug dbo:ChemicalSubstance n15:ChemicalObject wikidata:Q8386
rdfs:label
N-Ethylpentylone
rdfs:comment
N-Ethylpentylone (β-keto-ethylbenzodioxolylpentanamine, βk-ethyl-K, βk-EBDP, ephylone) is a substituted cathinone and stimulant drug which was developed in the 1960s. It has been reported as a novel designer drug in several countries including the United Kingdom, South Africa, New Zealand, the United States, and Australia. In 2018, N-ethylpentylone was the most common drug of the cathinone class to be identified in Drug Enforcement Administration seizures.
foaf:name
N-Ethylpentylone
foaf:depiction
n14:N-Ethylpentylone.png n14:N-Ethylpentylone.svg
dcterms:subject
dbc:Designer_drugs dbc:Serotonin–norepinephrine–dopamine_reuptake_inhibitors dbc:Cathinones dbc:Benzodioxoles
dbo:wikiPageID
56790392
dbo:wikiPageRevisionID
1114105473
dbo:wikiPageWikiLink
dbc:Serotonin–norepinephrine–dopamine_reuptake_inhibitors dbr:Isohexylone dbr:Substituted_cathinone dbr:IC50 dbr:Drug_Enforcement_Administration dbr:Norepinephrine_reuptake_inhibitor dbr:Hallucination dbr:Methylenedioxypyrovalerone dbr:Dipentylone dbr:Heart_palpitation dbr:Controlled_Substances_Act dbc:Cathinones dbr:Norepinephrine_transporter dbr:MDMA dbr:Stimulant dbr:N-Ethylheptylone dbr:N-Ethylpentedrone dbr:Serotonin_transporter dbr:N-Ethylhexedrone dbr:N-Ethylhexylone dbc:Benzodioxoles dbr:5-Methylethylone dbr:Eutylone dbr:Designer_drug dbr:Dopamine_reuptake_inhibitor dbr:Ethyl-K dbr:Dopamine_transporter dbr:Pentylone dbc:Designer_drugs
owl:sameAs
wikidata:Q55624327 n12:6Tvj3
dbp:wikiPageUsesTemplate
dbt:Drugbox dbt:Phenethylamines dbt:Clear dbt:Cascite dbt:Reflist dbt:Short_description dbt:Stimulants dbt:Fdacite dbt:Serotonergics
dbo:thumbnail
n14:N-Ethylpentylone.svg?width=300
dbp:atcPrefix
none
dbp:c
14
dbp:casNumber
17763 727641
dbp:chemspiderid
26949655
dbp:drugName
N-Ethylpentylone
dbp:h
19
dbp:image
N-Ethylpentylone.png
dbp:index2Label
HCl
dbp:iupacName
1
dbp:legalDe
Anlage II
dbp:legalUk
Class B
dbp:legalUs
Schedule I
dbp:n
1
dbp:o
3
dbp:pubchem
57359308
dbp:smiles
CCNCCc2ccc1OCOc1c2
dbp:stdinchi
1
dbp:stdinchikey
VERDHJIMZYXGIW-UHFFFAOYSA-N
dbp:unii
S3G8XZW25I D3H9D57JV9
dbo:abstract
N-Ethylpentylone (β-keto-ethylbenzodioxolylpentanamine, βk-ethyl-K, βk-EBDP, ephylone) is a substituted cathinone and stimulant drug which was developed in the 1960s. It has been reported as a novel designer drug in several countries including the United Kingdom, South Africa, New Zealand, the United States, and Australia. In 2018, N-ethylpentylone was the most common drug of the cathinone class to be identified in Drug Enforcement Administration seizures.
dbp:legalCa
Schedule I
dbp:legalUn
P II
prov:wasDerivedFrom
wikipedia-en:N-Ethylpentylone?oldid=1114105473&ns=0
dbo:wikiPageLength
9973
dbo:casNumber
17763-02-9 727641-67-0
dbo:fdaUniiCode
S3G8XZW25I D3H9D57JV9
dbo:pubchem
57359308
foaf:isPrimaryTopicOf
wikipedia-en:N-Ethylpentylone